Barclays’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Buy
+47,500
New +$12.6M ﹤0.01% 1059
2025
Q4
Sell
-85,000
Closed -$16.6M 5773
2025
Q3
$16.6M Buy
+85,000
New +$14M ﹤0.01% 1337
2024
Q4
Sell
-3,600
Closed -$189K 5526
2024
Q3
$189K Buy
+3,600
New +$169K ﹤0.01% 4334

Other funds holding ALAB

Barclays's ALAB Position: Q2 2026 in Review

Barclays reduced its Astera Labs (ALAB) stake by 27% in Q2 2026, selling an estimated $112M and leaving 1,130,944 shares worth $546M. The position accounts for 0.1% of the portfolio, ranked #125.

Barclays first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Barclays held 1,130,944 shares of Astera Labs worth $546M as of Q2 2026.
  • Barclays sold 423,236 Astera Labs shares in Q2 2026, an estimated $112M.
  • Astera Labs made up 0.1% of Barclays's portfolio in Q2 2026, its #125 holding.
  • Barclays first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.